Leerink Partners Remains Sidelined on Agios Pharma (AGIO) - PT to $56
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Agios Pharma (AGIO) Reports Q4 Loss of $1.08/Share
February 18, 2016 7:15 AM ESTAgios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.08), versus ($0.76) reported last year. Revenue for the quarter came in at $6.22 million, versus $14.64 million reported last year.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... MoreTrading Radar for 2/18: Wal-mart (WMT), Cabela's (CAB), Nordstrom (JWN), Leidos (LDOS), SodaStream (SODA) Report
February 17, 2016 3:18 PM EST(Updated - February 17, 2016 3:19 PM EST)
The Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
ALLETE, Inc. (NYSE: ALE) - consensus EPS $0.78
Aaron's (NYSE: AAN) - consensus EPS $0.38
Agios Pharma (Nasdaq: AGIO) - consensus loss $0.50
Atlas Air Worldwide... More



